deltatrials

Treatment resistant depression Trials in Boston, United States

Conditions / Treatment resistant depression / Boston, United States

Treatment resistant depression is a medical condition with active clinical research programs worldwide.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID Title Status Phase
NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD ACTIVE_NOT_RECRUITING PHASE3
NCT04608396 Mechanistic Evaluation of Response in TRD (MERIT) COMPLETED PHASE2
NCT04634669 Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) TERMINATED PHASE2
NCT05774665 Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression ACTIVE_NOT_RECRUITING PHASE2
NCT03152409 Salicylic Augmentation in Depression TERMINATED PHASE2
NCT03887715 A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression RECRUITING NA
NCT02417064 A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression COMPLETED PHASE3
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) RECRUITING
NCT04039022 Open-Label Safety Study of AXS-05 in Subjects With Depression COMPLETED PHASE3
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) RECRUITING

Related Pages